This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (173)

Published on in Vol 7, No 8 (2018): August

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Intra-Arterial TheraSphere Yttrium-90 Glass Microspheres in the Treatment of Patients With Unresectable Hepatocellular Carcinoma: Protocol for the STOP-HCC Phase 3 Randomized Controlled Trial

Authors of this article:

Nikhil Chauhan1 Author Orcid Image ;   Janet Bukovcan1 Author Orcid Image ;   Eveline Boucher1 Author Orcid Image ;   David Cosgrove2 Author Orcid Image ;   Julien Edeline3 Author Orcid Image ;   Bonnie Hamilton1 Author Orcid Image ;   Laura Kulik4 Author Orcid Image ;   Fayaz Master1 Author Orcid Image ;   Riad Salem5, 6, 7 Author Orcid Image
Article Authors Cited by (34) Tweetations (1) Metrics

Journals

  1. Facciorusso A, Bargellini I, Cela M, Cincione I, Sacco R. Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers 2020;12(4):897 View
  2. Forner A, Da Fonseca L, Díaz-González Á, Sanduzzi-Zamparelli M, Reig M, Bruix J. Controversies in the management of hepatocellular carcinoma. JHEP Reports 2019;1(1):17 View
  3. Tiwari T, Malone C, Foltz G, Akinwande O, Ramaswamy R. Yttrium-90 Radioembolization: Current Clinical Practice and Review of the Recent Literature. Journal of Radiology Nursing 2019;38(2):86 View
  4. Dietze M, Kunnen B, Beijst C, de Jong H. Adaptive scan duration in SPECT: Evaluation for radioembolization. Medical Physics 2020;47(5):2128 View
  5. Delhaye C, Hendlisz A, Vouche M. Update on transarterial approaches to locoregional treatment in hepatocellular carcinoma. Current Opinion in Oncology 2019;31(4):339 View
  6. Helmberger T, Arnold D, Bilbao J, de Jong N, Maleux G, Nordlund A, Peynircioglu B, Sangro B, Sharma R, Walk A. Clinical Application of Radioembolization in Hepatic Malignancies: Protocol for a Prospective Multicenter Observational Study. JMIR Research Protocols 2020;9(4):e16296 View
  7. Gabr A, Entezari P, Riaz A, Salem R, Lewandowski R. Contemporary Techniques and Applications of Radioembolization in Patients with Hepatocellular Carcinoma. Advances in Clinical Radiology 2020;2:113 View
  8. Kafrouni M, Allimant C, Fourcade M, Vauclin S, Guiu B, Mariano-Goulart D, Ben Bouallègue F. Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy. EJNMMI Research 2019;9(1) View
  9. Sofocleous C, Vasiniotis Kamarinos N. Tumor Radiation–absorbed Dose: The Missing Link in Radioembolization. Radiology 2020;296(3):685 View
  10. Abdallah M, Wongjarupong N, Hassan M, Taha W, Abdalla A, Bampoh S, Onyirioha K, Nelson M, Glubranson L, Wiseman G, Fleming C, Andrews J, Mahipal A, Roberts L. The efficacy, safety, and predictors of outcomes of transarterial radioembolization for hepatocellular carcinoma: a retrospective study. Expert Review of Gastroenterology & Hepatology 2020;14(7):619 View
  11. Sprave T, Grabbert M, Gratzke C, Ruf J, Bamberg F, Grosu A. Das oligometastasierte Prostatakarzinom: lokale Therapie. Der Onkologe 2020;26(9):782 View
  12. Allaire M, Goumard C, Lim C, Le Cleach A, Wagner M, Scatton O. New frontiers in liver resection for hepatocellular carcinoma. JHEP Reports 2020;2(4):100134 View
  13. Pillai A, Ahn J, Kulik L. Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges Ahead. American Journal of Gastroenterology 2020;115(12):1960 View
  14. Kloeckner R, Galle P, Bruix J. Local and Regional Therapies for Hepatocellular Carcinoma. Hepatology 2021;73(S1):137 View
  15. Goh M, Kang W, Sinn D, Gwak G, Paik Y, Choi M, Lee J, Koh K, Paik S. Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy. Journal of Liver Cancer 2020;20(2):160 View
  16. Marqueen K, Kim E, Ang C, Mazumdar M, Buckstein M, Ferket B. Cost-Effectiveness Analysis of Selective Internal Radiotherapy With Yttrium-90 Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma. JCO Oncology Practice 2021;17(2):e266 View
  17. Blanc J, Debaillon-Vesque A, Roth G, Barbare J, Baumann A, Boige V, Boudjema K, Bouattour M, Crehange G, Dauvois B, Decaens T, Dewaele F, Farges O, Guiu B, Hollebecque A, Merle P, Selves J, Aparicio T, Ruiz I, Bouché O. Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI). Clinics and Research in Hepatology and Gastroenterology 2021;45(2):101590 View
  18. Cassinotto C, Nogue E, Morell M, Panaro F, Molinari N, Guiu B. Changing trends in hepatocellular carcinoma management: Results from a nationwide database in the last decade. European Journal of Cancer 2021;146:48 View
  19. Parikh N, Pillai A. Recent Advances in Hepatocellular Carcinoma Treatment. Clinical Gastroenterology and Hepatology 2021;19(10):2020 View
  20. Facciorusso A, Paolillo R, Tartaglia N, Ramai D, Mohan B, Cotsoglou C, Chandan S, Ambrosi A, Bargellini I, Renzulli M, Sacco R. Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysis. Digestive and Liver Disease 2022;54(3):316 View
  21. Welling M, Duszenko N, van Meerbeek M, Molenaar T, Buckle T, van Leeuwen F, Rietbergen D. Microspheres as a Carrier System for Therapeutic Embolization Procedures: Achievements and Advances. Journal of Clinical Medicine 2023;12(3):918 View
  22. Viñal D, Minaya-Bravo A, Prieto I, Feliu J, Rodriguez-Salas N. Ytrrium-90 transarterial radioembolization in patients with gastrointestinal malignancies. Clinical and Translational Oncology 2022;24(5):796 View
  23. Burrel M, Bermúdez P, Forner González A. Perspectives for yttrium-90 radioembolization as therapeutic option for hepatocellular carcinoma. Revista Española de Enfermedades Digestivas 2022;114 View
  24. Hatzidakis A, Müller L, Krokidis M, Kloeckner R. Local and Regional Therapies for Hepatocellular Carcinoma and Future Combinations. Cancers 2022;14(10):2469 View
  25. Chung S, Gogna A, Chandramohan S, Lo R, Irani F, Venkatanarasimha N. Review of outcomes of combination therapy using yttrium 90 radioembolization and sorafenib/nivolumab for HCC with hepatic vein or IVC invasion. Proceedings of Singapore Healthcare 2023;32 View
  26. Garin E, Pinaquy J, Bailly C, Sengel C, Mariano-Goulart D, Edeline J, Blanc J, Bouvier A, Tordo J, Rode A, Becker S, Sefrioui D, de Baere T, Somma C, Mastier C, Goupil J, Chevallier P, Regnault H, Vibert E, Manfredi S, Vicaut E, Patel B, Boucher E, Guiu B. Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in France. CardioVascular and Interventional Radiology 2022;45(1):1 View
  27. Tong Q, Li R, Wang R, Zuo C, Li D, Jia G, Peng Y, Li X, Yang J, Xue S, Bai Q, Li X. The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization. Frontiers in Bioengineering and Biotechnology 2022;10 View
  28. Makary M, Ramsell S, Miller E, Beal E, Dowell J. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons. World Journal of Gastroenterology 2021;27(43):7462 View
  29. Gulec S, McGoron A. Radiomicrosphere Dosimetry: Principles and Current State of the Art. Seminars in Nuclear Medicine 2022;52(2):215 View
  30. Shannon A, Manne A, Diaz Pardo D, Pawlik T. Combined radiotherapy and immune checkpoint inhibition for the treatment of advanced hepatocellular carcinoma. Frontiers in Oncology 2023;13 View
  31. Thornton L, Abi-Jaoudeh N, Lim H, Malagari K, Spieler B, Kudo M, Finn R, Lencioni R, White S, Kokabi N, Jeyarajah D, Chaudhury P, Liu D. Combination and Optimal Sequencing of Systemic and Locoregional Therapies in Hepatocellular Carcinoma: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. Journal of Vascular and Interventional Radiology 2024;35(6):818 View
  32. Khalid M, Likhitsup A, Parikh N. Embolic and Ablative Therapy for Hepatocellular Carcinoma. Clinics in Liver Disease 2025;29(1):87 View

Books/Policy Documents

  1. Schaefer N. Nuclear Medicine Therapy. View
  2. Li C, Hickey R, Lewandowski R, Salem R. IR Playbook. View